Author(s):
Konathala Anusha, Ashritha Narikimalli, Mounika Mortha
Email(s):
ashrithanarikimalli@yahoo.com
DOI:
10.52711/0974-360X.2026.00077 
Address:
Konathala Anusha1, Ashritha Narikimalli1*, Mounika Mortha1
1Department of Pharmaceutical Analysis, School of Pharmaceutical Sciences and Technologies, Jawaharlal Nehru Technological University, Kakinada, Kakinada – 533003, Andhra Pradesh, India.
*Corresponding Author
Published In:
Volume - 19,
Issue - 2,
Year - 2026
ABSTRACT:
The present effort’s objective is developing an environmentally friendly, operator-safe RP-HPLC procedure for the concurrent quantification of Teneligliptin (TEN) and Pioglitazone (PIO) in bulk as well as tablets and validating as per criteria of ICH. Kromasil C18 column, mobile phase consisting 60 volumes of Ammonium acetate buffer (pH 3) along with 40 volumes of Acetonitrile forced at 1ml/min flow rate for the chromatographic separation using PDA. Separation of TEN and PIO was achieved at respective retention times of 2.470 min and 3.174 min. ICH recommendations Q2(R1) were utilized to validate the present procedure. The procedure was perceived to be linear in the concentration ranges of 5-30 µg/ml and 3.75-22.5 µg/ml respectively, for TEN and PIO. The detection and quantification limits for TEN and PIO were 0.07(µg/ml), 0.05(µg/ml) and 0.22(µg/ml), 0.15(µg/ml) respectively. ICH recommendations Q1A(R2) and Q1B were observed for executing forced degradation studies. Various metrics like AGREE, MoGAPI and BAGI were utilized for greenness and applicability assessment of the proposed technique. The procedure can be utilized for routine laboratory determination and quality control focused on the concurrent quantification of TEN and PIO.
Cite this article:
Konathala Anusha, Ashritha Narikimalli, Mounika Mortha. RP-HPLC Procedure Development and Validation for Teneligliptin and Pioglitazone Concurrent Quantification in Bulk and Pharmaceuticals with greenness and practicality assessment. Research Journal of Pharmacy and Technology. 2026;19(2):527-4. doi: 10.52711/0974-360X.2026.00077
Cite(Electronic):
Konathala Anusha, Ashritha Narikimalli, Mounika Mortha. RP-HPLC Procedure Development and Validation for Teneligliptin and Pioglitazone Concurrent Quantification in Bulk and Pharmaceuticals with greenness and practicality assessment. Research Journal of Pharmacy and Technology. 2026;19(2):527-4. doi: 10.52711/0974-360X.2026.00077 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-2-6
7. REFERENCES:
1. Nachiket D, Ganesh S, Jyoti V. Simultaneous estimation, validation and force degradation study of metformin hydrochloride and empagliflozin by RP-HPLC method. Research Journal of Science and Technology. 2019; 11(2): 135-47. https://doi.org/10.5958/2349-2988.2019.00021.4
2. Rahul G, Ganesh S, Shraddha J. Simultaneous estimation and validation of dapagliflozin and saxagliptin in bulk drug and dosage form by RP-HPLC. Research Journal of Science and Technology. 2019; 11(1): 59-63. https://doi.org/10.5958/2349-2988.2019.00008.1
3. Santosh J, Sanjay P, Virendra Y, Ashpak T. Zero-order and area under curve spectrophotometric methods for determination of atenolol in pharmaceutical formulation. Research Journal of Pharmaceutical Dosage Forms and Technology. 2015 Jan; 7(3): 185-9. https://doi.org/10.5958/0975-4377.2015.00027.0
4. Anand C, Murli K. Evaluation and marker quantification of antidiabetic herbal tablets: Steve Tab and Andro Tab by HPLC method. Research Journal of Pharmaceutical Dosage Forms and Technology. 2013 Feb; 5(1): 17-21.
5. Humphrey PR, Maureen MD, James MR, Flower RJ. Rang and Dale’s Pharmacology. Churchill Livingstone, New York. 2004.
6. Drug Bank. Teneligliptin. Available from: www.drugbank.ca/ drugs/DB11950. Accessed March 4, 2023.
7. Pallavi SH, Raman C. Analytical Method Development and Validation Studies of Anti Diabetic Drugs by HPLC. International Journal of Creative Research Thoughts. 2021; Nov.9(11): a740-745.
8. Drug Bank. Pioglitazone. Available from: www.drugbank.ca/ drugs/DB11320. Accessed February 4, 2019.
9. Meenaxi M, Nikhil SG, Utkarsh S, Poonam S. RP-HPLC Method Development and Validation for Pioglitazone in Bulk and Marketed Formulation. Der Pharma Chemica. 2021; 13(6): 6-15.
10. Mehul MP, Divya P, Umang S, Heta MK. A Simple, Precise, and Sensitive RP-HPLC Method for Quantification of Teneligliptin Hydrobromide and Metformin Hydrochloride: Development and Validation. Research Journal of Pharmaceutical Technology. 2023; 16(2): 495. https://doi.org/10.52711/0974-360X.2023.00084
11. Chandana M, Rao D, Samrajyam B, Sireesha K, Premi V. Analytical method development and validation of Teniligliptin in Pharmaceutical dosage form by RP-HPLC method. IJRDO -Journal of Health Sciences and Nursing. 2016 Dec; 1(12): 01-12. https://doi.org/10.53555/hsn.v1i12.844
12. Rajani V, Rajendra PY, Lakshmana A. Development and Validation of a Stability Indicating RP-HPLC Method for Simultaneous Estimation of Teneligliptin and Metformin. Turkish Journal of Pharmaceutical Sciences. 2020 April; 17(2): 141-147. https://doi.org/10.4274/tjps.galenos.2018.16768
13. Gadapa N, Upendra T. RP-HPLC Analytical method development and validation for simultaneous estimation of three drugs: Glimepiride, Pioglitazone, and Metformin and its pharmaceutical dosage forms. Journal of Chemistry. 2012 June 07; Article ID 726235, 1-8. https://doi.org/10.1155/2013/726235
14. Patel PH, Sharma P. Overview of analytical techniques on Teneligliptin hydrobromide hydrate, Pioglitazone hydrochloride, Metformin hydrochloride and their combinations. International Journal of Biology, Pharmacy and Allied Sciences. 2024 Oct; 13(10): 5066-5076. https://doi.org/10.31032/IJBPAS/2024/ 13.10.8397
15. Prem KB, Jeevan KK, Suthakaran R, Shankar C. Development and Validation of an Analytical Method for the Estimation of Metformin and Teneligliptin in its Bulk and Tablet Dosage Form by using RP-HPLC. Asian Journal of Pharmaceutical Analysis. 2020; 10(1): 11-14. https://doi.org/10.5958/2231-5675.2020.00003.4
16. Meeta AJ, Pandya SS, Viidyasagar G. A Simple and Sensitive HPTLC Method for Estimation of Pioglitazone In Bulk and Tablet Dosage Forms. Asian Journal of Research in Chemistry. June, 2009; 2(2): 207-209. https://doi.org/10.5958/0974-4150
17. Kalai SP, Venkatachalam T, Kishore VK, Lalitha KG. RP-HPLC Method for Simultaneous Determination of Pioglitazone and Telmisartan in Tablet Dosage Form. Asian Journal of Research in Chemistry. 2010; 3(3): 585-587. https://doi.org/10.5958/0974-4150
18. Madhuri DG, Koshish BG, Dinesh MS. Simultaneous Spectrophotometric Estimation of Glimepiride and Pioglitazone HCl in Combined Dosage Form using Absorbance Correction Method. Asian Journal of Research in Chemistry. 2011; 4(12): 1851-1853.
19. Varma DS, Dighe PR. Analytical Methods of Anti diabetic Drugs – Sitagliptin, Saxagliptin, Linagliptin, Alogliptin, Gemifibrozil, Troglitazone, Pioglitazone and Rosiglitazone: A Review. Research Journal of Pharmaceutical Dosage Forms and Technology. 2022; 14(4): 324. https://doi.org/10.52711/0975-4377.2022.00053
20. Yashpal NM, Channa BKP, Tamizh MT, Roopa K. Validated RP-HPLC Method for the Quantitation of Pioglitazone an Anti - Diabetic Drug in Bulk and Pharmaceutical Dosage Forms. Research Journal of Pharmacy and Technology. 2010; 3(3): 885-887.
21. Harsh HL, Ashvinkumar VD. Stability Indicating Method for Simultaneously Estimation of Teneligliptin, Pioglitazone and Metformin Hydrochloride in Combined Tablet Dosage form by RP-HPLC. Research Journal of Science and Technology. 2025; 17(2): 101-8. https://doi.org/10.52711/2349-2988.2025.00014
22. Sonali DR, Patil PM, Jadhav SB, Chaudhari PD. UV Spectrophotometric Simultaneous Determination of Metformin Hydrochloride and Pioglitazone Hydrochloride in Combined Dosage Form. Asian Journal of Pharmaceutical Analysis. 2012; 2(1): 05-09
23. Rajini T, Akiful HM, Veena K, Sireesha D, Harshini S, Vasudha B. Development and Validation for the Simultaneous Estimation of Pioglitazone Hydrochloride and Glimepiride in Mixed Dosage Form by RP-HPLC Method. Asian Journal of Research in Chemistry. December 2015; 8(12): 711-715. https://doi.org/ 10.5958/0974-4150.2015.00114.5
24. Deepa RP, Laxmanbhai JP, Madhabhai MP. Stability Indicating HPLC Method for Simultaneous Determination of Glimepride, Pioglitazone Hydrochloride and Metformin Hydrochloride in Pharmaceutical Dosage Form. Research Journal of Science and Technology. April 2011; 4(4): 606-611.
25. Jinal G, Dilip M. Development and Validation of UV Spectrophotometric Method and RP–HPLC Method for Simultaneous Estimation of Teneligliptin and Pioglitazone In Synthetic Mixture. Asian Journal of Pharmaceutical Technology and Innovation. 2017 Apr 15; 05(23): 66-78.
26. Mahesh K, Sameer G, Kavita V, Rohit B. Development and validation of the method for simultaneous estimation of Tenegliptin and Pioglitazone by UHPLC method. International Journal of Pharmaceutical Investigation. 2024 Apr 02; 14(2): 577-584. http://dx.doi.org/10.5530/ijpi.14.2.69
27. Ashok A, Harsh G, Sagar P, Jasmina S, Divya S, Ketan S, Tejas P, Sagar P. Stability Indicating TLC-Densitometric and HPLC methods for simultaneous determination of Tenegliptin and Pioglitazone in pharmaceutical dosage form with ECO-Friendly assessment. Journal of Chromatographic Science. 2025 Jan 14; 63(2): bmae038. https://doi.org/10.1093/chromsci/bmae038
28. Eman AB, Hisham H, Hanaa S, Maya E. Stability-indicating HPLC-DAD and TLC-densitometry methods for the quantification of bupivacaine and meloxicam in their co-formulated mixture. Microchemical Journal. 2023 Apr; 190(7): 108683. https://doi.org/10.1016/j.microc.2023.108683
29. Michael GF, Ebraam BK. Sustainable stability-indicating spectra manipulations for the concurrent quantification of a novel anti-COVID-19 drug and its active metabolite: green profile assessment. Spectrochimica acta. Part A, Molecular and Biomolecular Spectroscopy. 2023 Nov 5; 300: 122911. https://doi.org/10.1016/j.saa.2023.122911
30. Snyder LR, Kirkland JJ, Glajch JL. Practical HPLC method development and validation. John Wiley, New York 1979.
31. ICH Validation of analytical procedures: Text and methodology Q2(R1). In: ICH harmonised Tripartite guideline 2005.
32. ICH Stability testing of new drug substances and products Q1A(R2). In: ICH harmonised Tripartite guideline 2003.
33. ICH Stability testing: Photostability testing of new drug substances and products Q1B. In: ICH harmonised Tripartite guideline 2013.
34. Agnieszka G, Zdzisław M, Jacek N. The 12 principles of green analytical chemistry and the SIGNIFICANCE mnemonic of green analytical practices. Trends in Analytical Chemistry. 2013; 50(2013): 78-84. https://doi.org/10.1016/j.trac.2013.04.010
35. Płotka WJ. A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index. Talanta. 2018 May 01; 181:204-209. https://doi.org/10.1016/j.talanta.2018.01.013
36. Francisco PP, Wojciech W, Marek T. AGREE Analytical GREEnness Metric Approach and Software. Analytical Chemistry. 2020 Jul 21; 92(14): 10076-82. https://doi.org/ 10.1021/acs.analchem.0c01887
37. Mansour FR, Płotka WJ, Locatelli M. Modified GAPI (MoGAPI) Tool and Software for the Assessment of Method Greenness: Case Studies and Applications. Analytica. 2024 Sep 06; 5(3): 451-457. https://doi.org/10.3390/analytica5030030
38. Manousi N, Wojciech W, Justyna P. Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality. Green Chemistry. 2023 Aug 22; 25: 7598-7604. https://doi.org/10.1039/d3gc02347h